B
Bull
Bull · 25%SMLR
$37.14
Scenario price
$20.330
-0.990 (-4.87%)At close
Loading chart…
- High
- 21.390
- Open
- 21.370
- VWAP
- 20.66
- Vol
- 1.62M
- Mkt Cap
- 245.54M
- Low
- 20.270
- Amount
- 33.56M
- EV/EBITDA, TTM
- -13.59
Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
Analyst Ratings (1)
+150.86% upside
Buy
1 Buy
0 Hold
0 Sell
Current: 20.33
Low
51.00
Average
51.00
High
51.00
Maxim
Buy
$80
2025-09-19
Maxim
2025-09-19
Price Target
$80
Buy
Maxim
Buy
$95
2025-07-09
Maxim
2025-07-09
Price Target
$95
Buy
Lake Street
Strong Buy
$71
2025-01-24
Lake Street
2025-01-24
Price Target
$71
Strong Buy
B. Riley Securities
Hold
$45
2022-11-02
B. Riley Securities
2022-11-02
Price Target
$45
Hold
B. Riley Securities
Strong Buy
$60
2022-05-03
B. Riley Securities
2022-05-03
Price Target
$60
Strong Buy
Valuation Metrics
The current forward P/E ratio for Semler Scientific Inc (SMLR) is -14.57, compared to its 5-year average forward P/E of 18.01.
Alphio AI Price Scenarios for SMLR
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding SMLR
Events Timeline
News
8.501-16GlobenewswireStrive, Inc. Completes Semler Scientific Acquisition, Holds 12,797.9 Bitcoin
2.012-30Barron'sCrypto Treasury Stocks, Including Strategy, Encounter a Risky Downward Trend: Ways to Overcome It.
4.512-30Barron'sMSTR Stock: Strategies and Other Crypto Reserves Encounter a Risky Downward Trend.
8.512-12PRnewswireSemler Scientific to be Sold to Strive, Shareholders to Receive 21.05 Shares Each
8.512-09GlobenewswireWohl & Fruchter Investigates Semler-Strive Merger Fairness Amid Fixed Exchange Ratio Concerns
SMLR FAQ — answered by Alphio AI
Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
1 analysts cover SMLR: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 51.00.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.